iSpecimen
ISPC

iSpecimen (ISPC) earnings history

Most recent quarter

Period end
Sep 30, 2024
EPS actual
−$84.00
EPS estimate
−$152.00
Revenue
$2.7M
Reported
Nov 7, 2024

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2024Nov 7, 2024−$152.00−$84.00+44.74%$2.7MSEC
Q2 2024Aug 6, 2024−$224.00−$152.00+32.14%$2.9MSEC
Q1 2024May 7, 2024−$216.00−$256.00−18.52%$2.3MSEC
Q4 2023Mar 13, 2024−$192.00−$272.00−41.67%$2.6MSEC
Q3 2023Nov 2, 2023−$280.00−$184.00+34.29%$2.8MSEC
Q2 2023Aug 2, 2023−$240.00−$312.00−30.00%$1.6MSEC
Q1 2023May 4, 2023−$256.00−$216.00+15.63%$3.0MSEC
Q4 2022Mar 14, 2023−$300.00−$192.00+36.00%$3.2MSEC
Q3 2022Nov 8, 2022−$272.00−$280.00−2.94%$2.6M
Q2 2022Aug 4, 2022−$220.00−$240.00−9.09%$2.3M
Q1 2022May 10, 2022−$200.00−$216.00−8.00%$2.5M
Q4 2021Feb 17, 2022−$184.00−$216.00−17.39%$2.5M
Q3 2021Nov 4, 2021$0.00−$176.00+0.00%$2.7M

Quarterly revenue

Q3 2021
$2.7M
Q4 2021
$2.5M
Q1 2022
$2.5M
Q2 2022
$2.3M
Q3 2022
$2.6M
Q4 2022
$3.2M
Q1 2023
$3.0M
Q2 2023
$1.6M
Q3 2023
$2.8M
Q4 2023
$2.6M
Q1 2024
$2.3M
Q2 2024
$2.9M
Q3 2024
$2.7M

Frequently asked questions

  • When did iSpecimen (ISPC) last report earnings?

    iSpecimen last reported on Nov 7, 2024, covering fiscal Q3 2024.

  • Did ISPC beat earnings estimates?

    Yes. iSpecimen reported EPS of −$84.00 for Q3 2024 against a −$152.00 estimate — a 44.74% beat.

  • How much revenue did ISPC report last quarter?

    iSpecimen reported $2.7M in revenue for Q3 2024, against a consensus estimate of $2.9M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.